28 September 2015 - CADTH has received notice of a pending submission from Eisai for Fycompa (perampanel hemisesquihydrate) for patients with primary generalized tonic-clonic seizures.  For information about the patient input process or for additional instructions, please see the patient input page of the CADTH website.

For more details, go to: https://www.cadth.ca/fycompa